Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus standard rabbit ATG timing in haploidentical stem cell transplantation
IRCT20140818018842N20Phase 3Completed
- Sponsor
- Hematology, Oncology and Stem Cell Transplantation Research Center
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of antithymocyte globulin rabbit in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Hematology, Oncology and Stem Cell Transplantation Research Center. Primary endpoint: CMV reactivation. Started Nov 2021; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20140818018842N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N20.